Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.300
-0.050 (-1.15%)
At close: Mar 6, 2026, 4:00 PM EST
4.387
+0.087 (2.02%)
After-hours: Mar 6, 2026, 7:24 PM EST

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $2.17M in the quarter ending September 30, 2025, with 90.10% growth. This brings the company's revenue in the last twelve months to $5.20M, down -46.88% year-over-year. In the year 2024, Bolt Biotherapeutics had annual revenue of $7.69M, down -2.36%.

Revenue (ttm)
$5.20M
Revenue Growth
-46.88%
P/S Ratio
1.59
Revenue / Employee
$129,875
Employees
40
Market Cap
8.25M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.69M-186.00K-2.36%
Dec 31, 20237.88M2.15M37.48%
Dec 31, 20225.73M4.47M354.68%
Dec 31, 20211.26M1.03M445.45%
Dec 31, 2020231.00K16.00K7.44%
Dec 31, 2019215.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition